Stonehaven Incubate is a dedicated, animal health group committed to creating new companies from disruptive human technology. Nuritas, which combines artificial intelligence and genomics to discover and unlock natural Bioactive Peptides with extraordinary health benefits, is exactly the type of company with which it looks to forge partnerships.
Dr Mark Heffernan CEO of Stonehaven Incubate, said: “We see working with Nuritas on the use of its artificial intelligence platform to identify bioactive peptides as novel animal health solutions. The initial phase of our work together will include establishing a new company focused on this platform for animal health and conducting a series of evaluation trials.”
Emmet Browne, CEO of Nuritas, said: “We have long recognised the considerable opportunity for Nuritas within animal health. This partnership will deliver a unique and winning edge in this space by pairing Stonehaven Incubate’s deep industry specific understanding and experience with Nuritas’ ground-breaking technology.” Browne added: “The formation of the new company will enable us to focus on adding significant value to existing Nuritas discoveries in the field of animal health in addition to partnering externally on specific ground-breaking new projects. We have already experienced significant success with our unique discovery platform in the human world and now we are delighted to complement this with truly game-changing collaborations in the animal world.”
July 23, 2019 - Stonehaven Incubate